← Bandhan Mutual Fund

Bandhan BSE Healthcare Index Fund Direct Plan - Growth

Index/ETF Data as of Jul 2026 Comparing Jun 2026 → Jul 2026
Share: WhatsApp X
Stocks Held
125
Jul 2026
Equity Holdings
₹23.64 Cr
Equity only, excl. debt & cash
AAUM
₹18.92 Cr
Apr-Jun 2026 · Direct + Regular
Top 5 Weight
35.6%
Moderate
Top 10 Weight
55.6%
Moderate
Changes
92
1 new · 2 exits
Top Sector
Pharmaceuticals & Biotechnology
76.1% of portfolio
Launch Date
21 Aug 2024
2 years old

AAUM (Average Assets Under Management) of ₹18.92 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.

📋 What Happened This Month Bandhan BSE Healthcare Index Fund Direct Plan made 1 new addition and exited 2 stocks this month. The biggest new buy was Jupiter Life Line Hospitals Limited (Healthcare Services) at 0.38% weight. JB Chemicals & Pharmaceuticals Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 1.21%. Among existing holdings, Torrent Pharmaceuticals Limited saw the biggest increase — now at 4.53% of the portfolio. Dr. Reddy's Laboratories Limited was trimmed the most, now at 4.35%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 76.1%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 76.4% 75.8% -0.7%
Healthcare Services 23.3% 23.7% +0.4%
Healthcare Equipment & Supplies 0.5% 0.5% +0.1%
Jun 2026 Jul 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 75.8% 76.1% +0.4%
Healthcare Services 23.7% 23.3% -0.5%
Healthcare Equipment & Supplies 0.5% 0.5% 0.0%
🟢
Biggest New Buy
Jupiter Life Line Hospitals Limited
0.38% weight · Healthcare Services
🔴
Biggest Exit
JB Chemicals & Pharmaceuticals Limited
1.21% was held · Pharmaceuticals & Biotechnology
Biggest Add
Torrent Pharmaceuticals Limited
+1.52% · now 4.53%
Biggest Trim
Dr. Reddy's Laboratories Limited
-0.95% · now 4.35%
🤝 Other funds also bought this month
Jupiter Life Line Hospitals Limited 32 funds
Jupiter Life Line Hospitals Limited
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
SBI Multicap Fund- Direct Plan- Growth option
THE WEALTH COMPANY SMALL CAP FUND + more
👋 Other funds also exited
JB Chemicals & Pharmaceuticals Limited 160 funds
JB Chemicals & Pharmaceuticals Limited
Groww Nifty Smallcap250 ETF
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth
Mirae Asset Healthcare Fund Direct Growth + more
Jupiter Life Line Hospitals Ltd 32 funds
Jupiter Life Line Hospitals Ltd
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
SBI Multicap Fund- Direct Plan- Growth option
Groww BSE Hospitals ETF + more

What Changed in the Portfolio This Month?

Comparing Jun 2026 → Jul 2026

Jun 2026 Jul 2026
🟢 1 New Entry 🔴 2 Exits ↑ 29 Increased ↓ 60 Decreased
#StockSectorWeight (Jul 2026)
1
Jupiter Life Line Hospitals Limited
₹9.07 L
Healthcare Services 0.38%
#StockSectorLast Weight (Jun 2026)
1
JB Chemicals & Pharmaceuticals Limited
₹25.80 L
Pharmaceuticals & Biotechnology 1.21%
2
Jupiter Life Line Hospitals Ltd
₹7.29 L
Healthcare Services 0.34%
#StockSectorJun 2026Jul 2026Change
1
Torrent Pharmaceuticals Limited
₹1.07 Cr
Pharmaceuticals & Biotechnology 3.01% 4.53% +1.52%
2
Divi's Laboratories Limited
₹1.51 Cr
Pharmaceuticals & Biotechnology 5.37% 6.38% +1.01%
3
Laurus Labs Limited
₹1.02 Cr
Pharmaceuticals & Biotechnology 3.73% 4.33% +0.60%
4
Sun Pharmaceutical Industries Limited
₹3.16 Cr
Pharmaceuticals & Biotechnology 12.90% 13.35% +0.45%
5
Dr. Lal Path Labs Limited
₹21.63 L
Healthcare Services 0.81% 0.91% +0.10%
6
Piramal Pharma Limited
₹18.01 L
Pharmaceuticals & Biotechnology 0.67% 0.76% +0.09%
7
Abbott India Limited
₹20.84 L
Pharmaceuticals & Biotechnology 0.83% 0.88% +0.05%
8
Sai Life Sciences Limited
₹26.26 L
Pharmaceuticals & Biotechnology 1.07% 1.11% +0.04%
9
GlaxoSmithKline Pharmaceuticals Limited
₹15.87 L
Pharmaceuticals & Biotechnology 0.64% 0.67% +0.03%
10
Concord Biotech Limited
₹6.99 L
Pharmaceuticals & Biotechnology 0.27% 0.30% +0.03%
#StockSectorJun 2026Jul 2026Change
1
Dr. Reddy's Laboratories Limited
₹1.03 Cr
Pharmaceuticals & Biotechnology 5.30% 4.35% -0.95%
2
Max Healthcare Institute Limited
₹1.19 Cr
Healthcare Services 5.36% 5.05% -0.31%
3
Acutaas Chemicals Ltd
₹23.50 L
Pharmaceuticals & Biotechnology 1.17% 0.99% -0.18%
4
Fortis Healthcare Limited
₹72.36 L
Healthcare Services 3.20% 3.06% -0.14%
5
Cipla Limited
₹1.22 Cr
Pharmaceuticals & Biotechnology 5.31% 5.18% -0.13%
6
Lupin Limited
₹86.01 L
Pharmaceuticals & Biotechnology 3.76% 3.64% -0.12%
7
Mankind Pharma Limited
₹40.48 L
Pharmaceuticals & Biotechnology 1.82% 1.71% -0.11%
8
Aurobindo Pharma Limited
₹64.74 L
Pharmaceuticals & Biotechnology 2.82% 2.74% -0.08%
9
Syngene International Limited
₹10.74 L
Healthcare Services 0.53% 0.45% -0.08%
10
Krishna Institute Of Medical Sciences Limited
₹29.34 L
Healthcare Services 1.30% 1.24% -0.06%

What Stocks Does This Fund Hold?

125 stocks — Jul 2026

# Stock Sector Cap Weight & Value
1
₹3.16 Cr
Pharmaceuticals & Biotechnology
13.35%
2
₹1.51 Cr
Pharmaceuticals & Biotechnology
6.38%
3
₹1.34 Cr
Healthcare Services
5.68%
4
₹1.22 Cr
Pharmaceuticals & Biotechnology
5.18%
5
₹1.19 Cr
Healthcare Services
5.05%
6
₹1.07 Cr
Pharmaceuticals & Biotechnology
4.53%
7
₹1.03 Cr
Pharmaceuticals & Biotechnology
4.35%
8
₹1.02 Cr
Pharmaceuticals & Biotechnology
4.33%
9
₹86.01 L
Pharmaceuticals & Biotechnology
3.64%
10
₹72.36 L
Healthcare Services
3.06%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Bandhan Mutual Fund — Portfolio & Holdings
See all funds managed by Bandhan Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.